| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |